Status:
UNKNOWN
Increasing the Removal of Protein-Bound Solutes During Extended Hours Hemodialysis
Lead Sponsor:
Palo Alto Veterans Institute for Research
Conditions:
End Stage Renal Failure on Dialysis
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Hemodialysis keeps patients with renal failure alive but does not restore normal health. Retention of chemicals that bind to plasma proteins and are therefore poorly removed by dialysis may contribute...
Eligibility Criteria
Inclusion
- stable on nocturnal in-center dialysis located close to Stanford University and VA Palo Alto
Exclusion
- recent use of antibiotics
- gastrointestinal disease
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01892839
Start Date
July 1 2013
End Date
December 1 2016
Last Update
July 13 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Satellite Redwood City
Redwood City, California, United States, 94063
2
Stanford University
Stanford, California, United States, 94301